Loading clinical trials...
Loading clinical trials...
Pharmacokinetics and Metabolic Activation of Capecitabine When Given Concomitantly With Oxaliplatin and the Monoclonal Antibody Cetuximab
Conditions
Interventions
blood samples
Locations
3
Austria
PMU Salzburg
Salzburg, Salzburg, Austria
AKH Wien
Vienna, Vienna, Austria
Kaiser Franz Josef Spital
Vienna, Vienna, Austria
Start Date
February 1, 2012
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
March 9, 2015
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions